Wright1252943387.Pdf (1.09

Total Page:16

File Type:pdf, Size:1020Kb

Wright1252943387.Pdf (1.09 THE PRESYNAPTIC REGULATION OF ISOLATED NEONATAL RAT CAROTID BODY TYPE I CELLS BY HISTAMINE. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By DREW C. BURLON B.S., University of Dayton, 2006 2009 Wright State University WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES August 11th, 2009 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY Drew Burlon ENTITLED The Presynaptic Regulation of Neonatal Rat Carotid Body Type I Cells by Histamine BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science. ___________________________ Christopher N. Wyatt, Ph.D. Thesis Director ___________________________ Timothy C. Cope, Ph.D. Department Chair Signatures of Committee on Final Examination ______________________________ Christopher N. Wyatt, Ph.D. ______________________________ Robert W. Putnam, Ph.D. ______________________________ Kathrin L. Engisch , Ph.D. ______________________________ Joseph F. Thomas, Ph.D. Dean, School of Graduate Studies ABSTRACT Burlon, Drew C. M.S., Department of Neuroscience, Cell Biology and Physiology, Wright State University, 2009. The Presynaptic Regulation of Isolated Neonatal Rat Carotid Body Type I Cells by Histamine. It has been previously shown that Carotid Body Type I cells have the ability to synthesize, package and release histamine in response to hypoxia, thereby contributing to the modulation of respiration within the rat. Here, isolated neonatal rat carotid body type I cells were used to identify the presynaptic effects of histamine and the specific receptor subtypes that modulate them. Although all four histamine receptor subtypes are expressed on the type I cells, and preliminary data showed promising results, further data proved that the activation of these receptors with histamine or selective agonists caused 2+ no rise in intracellular calcium ([Ca ]i) and histamine did not augment calcium entry. Thus activation of histamine receptors on type I cells is unlikely to provide a presynaptic positive feedback mechanism during chemotransduction and any excitatory role attributed to the actions of histamine is likely to come from a postsynaptic effect on the carotid sinus nerve (CSN). Some of the data from this thesis have been accepted for publication in the journal Respiratory Physiology and Neurobiology: Burlon, D. C., Jordan, H. L. & Wyatt, C. N. (2009) Presynaptic regulation of isolated neonatal rat carotid body type I cells by histamine. Resp. Physiol and Neurobiol. 168, 218-223 iii TABLE OF CONTENTS Page I. INTRODUCTION ……………………………………………………………… 1 II. LITERATURE REVIEW ………………………………………………………. 4 General Anatomy………………………………………………………………... 5 History …………………………………………………………………………... 7 Chemotransduction by the Carotid Body (CB)…………………………………. 11 Role of the Type I cell as a Chemoreceptor…………………………………….. 18 a. The Mitochondrial Hypothesis……………………………………….. 13 b. The Membrane Hypothesis…………………………………………... 17 Neurotransmission within the Carotid Body……………………………………. 19 a. Excitatory Neurotransmitters: Post-Synaptic……………………….... 22 b. Excitatory Neurotransmitters: Pre-Synaptic………………………….. 25 c. Inhibitory Neurotransmitters: Pre-Synaptic………………………….. 26 Evidence for Histamine as an Excitatory Neurotransmitter within CB………… 27 H1 Receptor…………………………………………………………………….. 28 H2, H3 and H4 Receptors………………………………………………………. 29 Summary……………………………………………………………………....... 30 iv TABLE OF CONTENTS (CONT’D) III. MATERIALS AND METHODS……………………………………………….. 33 Dissection and Dissociation of CB Type I cells………………………………… 34 Immunocytochemistry…………………………………………………………... 36 Deconvolution Microscopy……………………………………………………... 37 FURA-2-AM……………………………………………………………………. 40 Ca2+ Imaging……………………………………………………………………. 44 Perfusion of Isolated Type I cells………………………………………………. 47 Statistical Analysis……………………………………………………………… 47 IV. RESULTS………………………………………………………………………. 48 Immunocytochemistry………………………………………………………….. 49 2+ Effect of Histamine on [Ca ]i………………………………………………….. 55 2+ 2+ Dependence of Histamine evoked rise in [Ca ]i on extracellular Ca ………... 58 2+ Effect of Histamine agonists on [Ca ]i………………………………………… 61 Concentration Dependence of Histamine Response……………………………. 70 2+ Effects of Histamine and Agonists on [Ca ]i with the Addition of O.7 ND filter. 75 V. DISCUSSION………………………………………………………………….. 8 Results Summary……………………………………………………………….. 88 Location of Histamine Receptors………………………...…………………….. 88 Cells Damaged By Enzyme Dissociation Process……………………………… 90 Artifact…………………………………………………………………………. 95 v TABLE OF CONTENTS (CONT’D) VI. FUTURE DIRECTIONS………………………………………………………. 96 VII. BIBLIOGRAPHY……………………………………………………………… 98 vi LIST OF FIGURES Page FIGURE 1. Structure and ultrastructure of the carotid body……………………..... 7 FIGURE 2. Isolation of a canines head connected with anastamoses to the isolated trunk of another animal………………………………………………... 10 FIGURE 3. Schematic showing the AMPK theory in detail……………………….. 15 FIGURE 4. Schematic showing neurotransmission within a glomoid in the carotid body…………………………………………………………………… 20 FIGURE 5. Representative image of deconvolution microscopy…………………. 37 FIGURE 6. Fluorescence emission of Fura-2 at differing wavelengths…………… 41 FIGURE 7. Screenshot from the Metafluor acquisition program………………….. 44 FIGURE 8. Histamine receptor subtype immunofluorescence in isolated carotid body type I cells……………………………………………………………... 50 FIGURE 9. Type I cells stained for Tyrosine Hydroxylase………………………... 52 FIGURE 10. Various effects of 100μM histamine on type I cell Fura-2 fluorescence ratio……………………………………………………………………. 55 FIGURE 11. Effects of 100µM histamine on type I cell Fura-2 Fluorescence ratios... 58 FIGURE 12. Pharmacological stimulation of the H1 histamine receptor subtype…... 61 FIGURE 13. Pharmacological stimulation of the H2 histamine receptor subtype…... 63 FIGURE 14. Pharmacological stimulation of the H3 histamine receptor subtype…... 65 FIGURE 15. Pharmacological stimulation of the H4 histamine receptor subtype…... 67 vii LIST OF FIGURES (CONT’D) FIGURE 16. Dose response experiments performed on individual type I glomus cells with no neutral density filter (300μM and 100μM Histamine)...……… 70 FIGURE 17. Dose response experiments performed on individual type I glomus cells with no neutral density filter (10μM and 0μM Histamine)……………. 72 FIGURE 18. Neutral density filter selection………………………………………… 76 FIGURE 19. Effects of 300μM histamine on type I cells with the incorporation of the 0.7 ND filter……………………………………………………………. 78 FIGURE 20. Pharmacological stimulation of the H1 histamine receptor subtype, with the incorporation of 0.7 ND filter……………………………………… 80 FIGURE 21. Pharmacological stimulation of the H2 histamine receptor subtype, with the incorporation of a 0.7 ND filter……………………………………. 82 FIGURE 22. Pharmacological stimulation of the H3 histamine receptor subtype, with the incorporation of a 0.7 ND filter……………………………………. 84 FIGURE 23. Graph representing intact G-protein receptor complexes in the plasma membrane of Type I cells……………………………………………… 92 FIGURE 24. Graph determining whether or not histamine amplifies Ca2+ influx by regulating voltage gated calcium channels…………………………….. 94 viii ACKNOWLEDGEMENTS I would really like to thank Dr. Christopher Wyatt for his relentless support of me during the arduous process of completing this thesis project. He was incredibly handsome and brilliant, which I think are the two best qualities to have in a primary investigator. Also, a special thanks to Robert Putnam, Ph.D and Kathrin Engisch, Ph.D for listening to my preliminary talks and providing great feedback in areas that needed improvement; it helped my thesis proceed much more smoothly. I would also really like to thank Barbara Barr for her lab awareness and protocol expertise as well as Andrew Jenkins and Heidi Jordan. And last but not least, I need to thank my family: Dan, Konnie, Brett, Jessica, Dave, Aidan, Evan, Julia and Megan. If they weren’t in my life it just wouldn’t be as cool. ix CHAPTER I INTRODUCTION 1 Why do we need to breathe? Is it an important function? What controls our breathing? Ever since oxygen became a freely accessible molecule on planet earth, organisms have been using it to fuel cellular respiration. Cellular respiration, or the process of using oxygen to produce ATP in mitochondria, is what allowed life to flourish and diversify on earth. Because of oxygen’s role as the final electron acceptor in the electron transport chain, single as well as multi cellular organisms have the ability to increase their energy production. In animals, respiration is the process through which oxygen is exchanged in the lungs for carbon dioxide, a byproduct of cellular respiration. By inhaling air into our lungs, oxygen is delivered to the blood stream. The blood then transports oxygen to all the cells of the body, and allows for cellular respiration to take place. This fundamental process is pivotal for human life to exist as we know it. For millennia man has known breathing, or respiration, was integral for survival. What was not known however, were the structures and processes involved with the control of our breathing. Toward the beginning of the 20th century breathing was discovered to be influenced by specialized organs that sensed changes in the composition + of the body fluids (PO2, PCO2, or [H ]), which reflect O2 demands and CO2 production (Heymans, 1930; Gonzalez et al., 1994). These organs were designated the peripheral arterial chemoreceptors. Later, during the middle of the century chemoreceptor sites within the brain
Recommended publications
  • Multidimensional Analysis of Extended Molecular Dynamics Simulations Shows the Complexity of Signal
    bioRxiv preprint doi: https://doi.org/10.1101/604793; this version posted April 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. TITLE Multidimensional analysis of extended molecular dynamics simulations shows the complexity of signal transduction by the histamine H3 membrane receptor Short title: Molecular dynamics of signal transduction AUTHORS Herrera-Zuniga LD1,4, Moreno-Vargas LM2,4, Correa-Basurto J1,3, Prada D2, Curmi P1, Arrang, JM4, Maroun, RC1,4* 1 SABNP, UMR-S U1204, INSERM/Université d’Evry-Val d’Essonne/Université Paris-Saclay, 91025 Evry, FRANCE 2 Computational Biology and Drug Design Research Unit. Federico Gomez Children's Hospital of Mexico City, MEXICO 3 Laboratory for the Design and Development of New Drugs and Biotechnological Innovation) SEPI-ESM, MEXICO 4 INSERM U894, Paris, FRANCE *Corresponding author 1 bioRxiv preprint doi: https://doi.org/10.1101/604793; this version posted April 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT In this work, we study the mechanisms of activation and inactivation of signal transduction by the histamine H3 receptor (H3R), a 7TM GPCR through extended molecular dynamics (MD) simulations of the receptor embedded in a hydrated double layer of dipalmitoyl phosphatidyl choline (DPPC), a zwitterionic poly-saturated ordered lipid. Three systems were prepared: the apo H3R, representing the constitutively active receptor; and the holo-systems: the H3R coupled to an antagonist/inverse agonist (ciproxifan) and representing the inactive state of the receptor; and the H3R coupled to the endogenous agonist histamine and representing the active state of the receptor.
    [Show full text]
  • Human Histamine H2 Receptor, Frozen Cells Product No.: ES-391-AF
    TECHNICAL AequoZen® DATA SHEET Research use only. Not for use in diagnostic procedures. You are authorized to utilize these frozen cell preparations one time only. Any attempt to transfer, re-use, or propagate these cells is expressly unauthorized and a violation of the product terms and conditions of sale. Human Histamine H2 Receptor, Frozen Cells Product No.: ES-391-AF Lot No.: 2562845 Material Provided Cells: 1 x 1 mL frozen aliquot Format: ~10 x 106 cells/mL in Ham’s F12, 10% FBS with 10 % DMSO Product Information Cellular Background: CHO-K1 Parental Frozen Cells (control): A19 (replaced with Cat # ES-000-A2F) Frozen Cells Info: Frozen recombinant, CHO-K1 cells expressing mitochondrially- targeted Aequorin, Gα16 and the human Histamine H2 receptor. DNA Sequence: Identical to coding sequence of GenBank NM_022304.2. Corresponding Protein Sequence: Identical to GenBank NP_071640.1. Storage Conditions: Store in liquid nitrogen (vapor phase) immediately upon receipt, or maximum 15 days at -80°C. AequoZen® is designed for single use only. Do not refreeze. Quality Control ® EC50 for a reference agonist is determined using an AequoScreen assay (Figure 1). Mycoplasma test is performed using MycoAlert® Mycoplasma detection kit. We certify that these results meet our quality release criteria. Amthamine dihydrobromide (EC50): 6.9 nM Mycoplasma: This cell line tested negative for Mycoplasma. TDS-ES-391-AF-04 Page 1 of 5 Recommended Thawing Conditions and Handling of Frozen Cells Carefully follow instructions below to obtain the expected results. Most Frozen cells are intended to be assayed immediately upon thawing. Exceptionally, where specified, some frozen cell products require an overnight incubation in Cell Medium to enable them to perform optimally.
    [Show full text]
  • Chapter 2 Molecular Aspects of Histamine Receptors
    VU Research Portal Shedding Light on the Histamine H3 Receptor Mocking, T.A.M. 2020 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Mocking, T. A. M. (2020). Shedding Light on the Histamine H3 Receptor: Photopharmacology and bioluminescent assays to study GPCRs. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 06. Oct. 2021 Chapter 2 Molecular aspects of histamine receptors Histamine mediates a multitude of physiological effects in the human body by activating four histamine receptor subtypes. Histamine receptors have proven to be promising drug targets in the treatment of a variety of diseases, including hay fever, gastric ulcers, inflammatory and neuropathological diseases. In this chapter the molecular aspects of histamine receptors are described, including expression profile, intracellular signaling, and how histamine receptor activity can be attenuated by ligands targeting the histamine receptor binding sites.
    [Show full text]
  • Histamine Receptors
    Tocris Scientific Review Series Tocri-lu-2945 Histamine Receptors Iwan de Esch and Rob Leurs Introduction Leiden/Amsterdam Center for Drug Research (LACDR), Division Histamine is one of the aminergic neurotransmitters and plays of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit an important role in the regulation of several (patho)physiological Amsterdam, De Boelelaan 1083, 1081 HV, Amsterdam, The processes. In the mammalian brain histamine is synthesised in Netherlands restricted populations of neurons that are located in the tuberomammillary nucleus of the posterior hypothalamus.1 Dr. Iwan de Esch is an assistant professor and Prof. Rob Leurs is These neurons project diffusely to most cerebral areas and have full professor and head of the Division of Medicinal Chemistry of been implicated in several brain functions (e.g. sleep/ the Leiden/Amsterdam Center of Drug Research (LACDR), VU wakefulness, hormonal secretion, cardiovascular control, University Amsterdam, The Netherlands. Since the seventies, thermoregulation, food intake, and memory formation).2 In histamine receptor research has been one of the traditional peripheral tissues, histamine is stored in mast cells, eosinophils, themes of the division. Molecular understanding of ligand- basophils, enterochromaffin cells and probably also in some receptor interaction is obtained by combining pharmacology specific neurons. Mast cell histamine plays an important role in (signal transduction, proliferation), molecular biology, receptor the pathogenesis of various allergic conditions. After mast cell modelling and the synthesis and identification of new ligands. degranulation, release of histamine leads to various well-known symptoms of allergic conditions in the skin and the airway system. In 1937, Bovet and Staub discovered compounds that antagonise the effect of histamine on these allergic reactions.3 Ever since, there has been intense research devoted towards finding novel ligands with (anti-) histaminergic activity.
    [Show full text]
  • Physiological Implications of Biased Signaling at Histamine H2 Receptors
    ORIGINAL RESEARCH published: 10 March 2015 doi: 10.3389/fphar.2015.00045 Physiological implications of biased signaling at histamine H2 receptors Natalia Alonso 1,2,CarlosD.Zappia2,3, Maia Cabrera 2,3, Carlos A. Davio 2,3,4 , Carina Shayo 1,2, Federico Monczor 2,3 and Natalia C. Fernández 2,3* 1 Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental, Buenos Aires, Argentina, 2 Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina, 3 Laboratorio de Farmacología de Receptores, Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina, 4 Instituto de Investigaciones Farmacológicas – Universidad de Buenos Aires – Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina Histamine mediates numerous functions acting through its four receptor subtypes all belonging to the large family of seven transmembrane G-protein coupled receptors. In particular, histamine H2 receptor (H2R) is mainly involved in gastric acid production, becoming a classic pharmacological target to treat Zollinger–Ellison disease and gastric Edited by: Claudio M. Costa-Neto, and duodenal ulcers. H2 ligands rank among the most widely prescribed and over University of São Paulo, Brazil the counter-sold drugs in the world. Recent evidence indicate that some H2R ligands Reviewed by: display biased agonism, selecting and triggering some, but not all, of the signaling Terry Kenakin, pathways associated to the H2R. The aim of the present work is to study whether University of North Carolina Chapel Hill, USA famotidine, clinically widespread used ligand acting at H2R, exerts biased signaling. Our Andre Sampaio Pupo, findings indicate that while famotidine acts as inverse agonist diminishing cAMP basal São Paulo State University, Brazil levels, it mimics the effects of histamine and the agonist amthamine concerning receptor *Correspondence: Natalia C.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,486,621 B2 Luo Et Al
    USOO8486.621B2 (12) United States Patent (10) Patent No.: US 8,486,621 B2 Luo et al. (45) Date of Patent: Jul. 16, 2013 (54) NUCLEICACID-BASED MATRIXES 2005. O130180 A1 6/2005 Luo et al. 2006/0084607 A1 4/2006 Spirio et al. (75) Inventors: ity, N. (US); Soong Ho 2007/01482462007/0048759 A1 3/20076/2007 Luo et al. m, Ithaca, NY (US) 2008.0167454 A1 7, 2008 Luo et al. 2010, O136614 A1 6, 2010 Luo et al. (73) Assignee: Cornell Research Foundation, Inc., 2012/0022244 A1 1, 2012 Yin Ithaca, NY (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this WO WO 2004/057023 A1 T 2004 patent is extended or adjusted under 35 U.S.C. 154(b) by 808 days. OTHER PUBLICATIONS Lin et al. (J Biomech Eng. Feb. 2004;126(1):104-10).* (21) Appl. No.: 11/464,184 Li et al. (Nat Mater. Jan. 2004:3(1):38-42. Epub Dec. 21, 2003).* Ma et al. (Nucleic Acids Res. Dec. 22, 1986;14(24):9745-53).* (22) Filed: Aug. 11, 2006 Matsuura, et al. Nucleo-nanocages: designed ternary oligodeoxyribonucleotides spontaneously form nanosized DNA (65) Prior Publication Data cages. Chem Commun (Camb). 2003; (3):376-7. Li, et al. Multiplexed detection of pathogen DNA with DNA-based US 2007/01 17177 A1 May 24, 2007 fluorescence nanobarcodes. Nat Biotechnol. 2005; 23(7): 885-9. Lund, et al. Self-assembling a molecular pegboard. JAm ChemSoc. Related U.S. Application Data 2005; 127(50): 17606-7. (60) Provisional application No. 60/722,032, filed on Sep.
    [Show full text]
  • International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
    1521-0081/67/3/601–655$25.00 http://dx.doi.org/10.1124/pr.114.010249 PHARMACOLOGICAL REVIEWS Pharmacol Rev 67:601–655, July 2015 Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics ASSOCIATE EDITOR: ELIOT H. OHLSTEIN International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors Pertti Panula, Paul L. Chazot, Marlon Cowart, Ralf Gutzmer, Rob Leurs, Wai L. S. Liu, Holger Stark, Robin L. Thurmond, and Helmut L. Haas Department of Anatomy, and Neuroscience Center, University of Helsinki, Finland (P.P.); School of Biological and Biomedical Sciences, University of Durham, United Kingdom (P.L.C.); AbbVie, Inc. North Chicago, Illinois (M.C.); Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany (R.G.); Department of Medicinal Chemistry, Amsterdam Institute of Molecules, Medicines and Systems, VU University Amsterdam, The Netherlands (R.L.); Ziarco Pharma Limited, Canterbury, United Kingdom (W.L.S.L.); Institute of Pharmaceutical and Medical Chemistry (H.S.) and Institute of Neurophysiology, Medical Faculty (H.L.H.), Heinrich-Heine-University Duesseldorf, Germany; and Janssen Research & Development, LLC, San Diego, California (R.L.T.) Abstract ....................................................................................602 Downloaded from I. Introduction and Historical Perspective .....................................................602 II. Histamine H1 Receptor . ..................................................................604 A. Receptor Structure
    [Show full text]
  • Histamine Inhibits the Production of Interleukin-12 Through Interaction with H2 Receptors
    Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. T C van der Pouw Kraan, … , R Leurs, L A Aarden J Clin Invest. 1998;102(10):1866-1873. https://doi.org/10.1172/JCI3692. Research Article IL-12 is essential for T helper 1 (Th1) development and inhibits the induction of Th2 responses. Atopic diseases, which are characterized by Th2 responses, are associated with the overproduction of histamine. Here we present evidence that histamine, at physiological concentrations, strongly inhibits human IL-12 p40 and p70 mRNA and protein production by human monocytes. The use of specific histamine receptor antagonists reveals that this inhibition is mediated via the H2 receptor and induction of intracellular cAMP. The inhibition of IL-12 production is independent of IL-10 and IFN-gamma. The observation that histamine strongly reduces the production of the Th1-inducing cytokine IL-12 implies a positive feedback mechanism for the development of Th2 responses in atopic patients. Find the latest version: https://jci.me/3692/pdf Histamine Inhibits the Production of Interleukin-12 through Interaction with H2 Receptors Tineke C.T.M. van der Pouw Kraan,* Alies Snijders,‡ Leonie C.M. Boeije,* Els R. de Groot,* Astrid E. Alewijnse,§ Rob Leurs,§ and Lucien A. Aarden* *CLB, Sanquin Blood Supply Foundation, Department of Auto-Immune Diseases, Laboratory for Experimental and Clinical Immunology, Academic Medical Centre, University of Amsterdam, 1066CX Amsterdam, The Netherlands; ‡Laboratory of Cell Biology and Histology, Academic Medical Centre, 1105 AZ Amsterdam, The Netherlands; and §Department of Pharmacochemistry, Free University, Leiden/Amsterdam Centre for Drug Research, 1081 HV Amsterdam, The Netherlands Abstract a Th2 response (4–6), while various organ-specific autoim- mune diseases are characterized by Th1-like responses (7).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0220580 A1 Rubin Et Al
    US 2016O220580A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0220580 A1 Rubin et al. (43) Pub. Date: Aug. 4, 2016 (54) SMALL MOLECULESCREENING FOR (60) Provisional application No. 61/497,708, filed on Jun. MOUSE SATELLITE CELL PROLIFERATION 16, 2011. (71) Applicant: PRESIDENT AND FELLOWS OF Publication Classification HARVARD COLLEGE, Cambridge, (51) Int. Cl. MA (US) A 6LX3/553 (2006.01) (72) Inventors: Lee L. Rubin, Wellesley, MA (US); A613 L/496 (2006.01) Amanda Gee, Alexandria, VA (US); A613 L/4439 (2006.01) Amy J. Wagers, Cambridge, MA (US) A613 L/404 (2006.01) (52) U.S. Cl. CPC ............. A6 IK3I/553 (2013.01); A61 K3I/404 (21) Appl. No.: 15/012,656 (2013.01); A61 K3I/496 (2013.01); A61 K 31/4439 (2013.01) (22) Filed: Feb. 1, 2016 (57) ABSTRACT The invention provides methods for inducing, enhancing or Related U.S. Application Data increasing satellite cell proliferation, and an assay for screen (63) Continuation-in-part of application No. 14/126,716, ing for a candidate compound for inducing, enhancing or filed on Jun. 13, 2014, now Pat. No. 9.248,185, filed as increasing satellite cell proliferation. Also provided are meth application No. PCT/US2012/042964 on Jun. 18, ods for repairing or regenerating a damaged muscle tissue of 2012. a Subject. Patent Application Publication Aug. 4, 2016 Sheet 1 of 44 US 2016/0220580 A1 FIG. A Patent Application Publication Aug. 4, 2016 Sheet 2 of 44 US 2016/0220580 A1 FIG. C. FIG. 2A Patent Application Publication Aug.
    [Show full text]
  • Evaluation of Anxiolytic Effects of Aripiprazole and Hydroxyzine As a Combination in Mice
    Original Article Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice Abstract Context: Anxiety disorders are chronic, common, and often comorbid. There is an unmet need in its treatment. Aripiprazole and hydroxyzine are well‑known therapeutic options used as monotherapy in clinics. They have different mechanisms and site of actions. Aim: The objective of the present study was to evaluate the anxiolytic effect of aripiprazole and hydroxyzine in combination. Materials and Methods: Swiss albino mice (male) received treatment of 5% of Tween 80 in 0.9% saline (10 ml/kg; control group), “aripiprazole alone” (1 mg/kg), “hydroxyzine alone” (3 mg/kg), and aripiprazole (0.5 mg/kg) + hydroxyzine (1.5 mg/kg) through the intraperitoneal route. Statistical Analysis Used: statistical analysis. One‑way ANOVA followed by Tukey’s honest significant difference was employed for Results: The in vivo outcomes (elevated plus maze, light/dark transition, and marble burying tests) of was found to be better than control and aripiprazole‑treated groups. The combination‑treated group showed hydroxyzine monotherapy‑treated group showed a significant anxiolytic activity. The combination‑treated group group but not better than the hydroxyzine group. The in vitro results were in compliance with the in vivo results. a significant increase in the level of serotonin in different brain regions as compared to aripiprazole‑treated monotherapy. However, hydroxyzine showed better anxiolytic activity when compared to control, aripiprazole The combinational approach was found to be beneficial in anxiolytic treatment as compared to aripiprazole monotherapy, and combination groups. Conclusions: The anxiolytic effect of combination‑treated group was found to be better than aripiprazole monotherapy and lesser than hydroxyzine monotherapy.
    [Show full text]
  • WO 2011/089216 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date t 28 July 2011 (28.07.2011) WO 2011/089216 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) C07K 1/13 (2006.01) kind of national protection available): AE, AG, AL, AM, C07K 1/1 07 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP201 1/050821 HN, HR, HU, ID, J , IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 2 1 January 201 1 (21 .01 .201 1) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 1015 1465. 1 22 January 2010 (22.01 .2010) EP kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): AS- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, CENDIS PHARMA AS [DK/DK]; Tuborg Boulevard TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 12, DK-2900 Hellerup (DK).
    [Show full text]
  • Antipsychotics for Amphetamine Psychosis. A
    Antipsychotics for Amphetamine Psychosis. A Systematic Review Dimy Fluyau, Emory University Paroma Mitra, New York University Kervens Lorthe, Miami Regional University Journal Title: Frontiers in Psychiatry Volume: Volume 10 Publisher: Frontiers Media | 2019-10-15, Pages 740-740 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.3389/fpsyt.2019.00740 Permanent URL: https://pid.emory.edu/ark:/25593/v48xp Final published version: http://dx.doi.org/10.3389/fpsyt.2019.00740 Copyright information: © Copyright © 2019 Fluyau, Mitra and Lorthe. This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/). Accessed October 1, 2021 4:49 PM EDT SYSTEMATIC REVIEW published: 15 October 2019 doi: 10.3389/fpsyt.2019.00740 Antipsychotics for Amphetamine Psychosis. A Systematic Review Dimy Fluyau 1*, Paroma Mitra 2 and Kervens Lorthe 3 1 School of Medicine, Emory University, Atlanta, GA, United States, 2 Langone Health, Department of Psychiatry, NYU, New York, NY, United States, 3 Department of Health, Miami Regional University, Miami Springs, FL, United States Background: Among individuals experiencing amphetamine psychosis, it may be difficult to rule out schizophrenia. The use of antipsychotics for the treatment of amphetamine psychosis is sparse due to possible side effects. Some arguments disfavor their use, stating that the psychotic episode is self-limited. Without treatment, some individuals may not fully recover from the psychosis and may develop full-blown psychosis, emotional, and cognitive disturbance. This review aims to investigate the clinical benefits and risks of antipsychotics for the treatment of amphetamine psychosis.
    [Show full text]